• Journal of Nutrition and Health
• /
• 제39권1호
• /
• pp.35-43
• /
• 2006

This study aimed to evaluate the effect of dietary fiber supplementation with snack type on functional constipation. We conducted a double blind case-control study with 3 groups; placebo, low dose group (LD: insoluble fiber 7 g/d + soluble fiber 1.2 g/d) and high dose group (HD: insoluble fiber 14 g/d + soluble fiber 2.4 g/d) , which were randomly assigned out of subjects with functional constipation, defined by modified Rome II criteria. We measured anthropometric parameters and evaluated the bowel movement frequency, stool type, straining, sense of complete evacuation, abdominal discomfort/pain, abdominal inflation, relief and colon transit time before, during the supplementation. Both LD and HD groups had significant improvement in straining, sense of complete evacuation and satisfactory relief compared with placebo group (p < 0.05). When subdivide by baseline colon transit time (less than 24 hrs/ 24 hrs or more and less than 72 hrs / 72 hrs or more), only HD group had significantly improvement; colon transit time recovered near by 24 hrs in subjects of 'less than 24 hrs' (from $7.57{\pm}1.40$ hrs to $25.2{\pm}3.91$ hrs, p < 0.01) and reduced in those of '24hr or more and less than 72 hr' (from $47.0{\pm}3.36$ hrs to $31.3{\pm}4.31$ hrs, p < 0.01) and '72 hr or more' (from $106.7{\pm}10.7$ hrs to $85.0{\pm}13.1$ hrs, P < 0.05) subjects. Particularly, positive effect of fiber supplementation on straining and sense of complete evacuation in test groups seemed to be greater in subjects of '24 hrs or less' and '24 hrs or more and less' than 72 hrs' than those of '72 hrs or more'. In conclusion, subjects with functional constipation, particularly those having colon transit time less than 72 hrs can significantly improve, at least in part, symptom related to constipation by fiber supplementation of snack type without serious side effects.

• 대한한방내과학회지
• /
• 제39권6호
• /
• pp.1296-1305
• /
• 2018

A patient with an epigastralgia was treated with Korean medicine for the short-term period of five days under admission care. In this case report, we discuss the efficacy and safety of short-term treatment using Korean medicine methods on a patient with an epigastralgia by evaluating a numerical rating scale, agastrointestinal symptom questionnaire, clinical features, and blood tests. The complex methods comprise purgation therapy using Crotonis Fructus, Korean herbal medication, acupuncture and moxibustion. Throughout the purgation therapy with Crotonis Fructus, the patient reported improvement in both her pain score and dyspepsia index. This case showed that Korean medicine acted not only fast, but also effective for treating epigastralgia patients diagnosed with functional dyspepsia.

• 대한한방내과학회지
• /
• 제23권2호
• /
• pp.244-252
• /
• 2002

Functional dyspepsia refers to upper abdominal pain or discomfort with or without symptoms of early satiety, nausea, or vomiting with no definable organic cause. In this study, we recognized that dyspepsia was decreased with herbal medication (Banhabakchulchunma-tang) and acupuncture therapy. And we aimed to evaluate the Gastrointestinal Symptoms Rating Scale (GSRS) in these cases. The GSRS indicated that Oriental medicine treatment could be effective in the Functional dyspepsia. And it is helpful in decreasing symptoms of patients and in improving quality of life.

• Journal of Ginseng Research
• /
• 제45권6호
• /
• pp.706-716
• /
• 2021

Background: Irritable bowel syndrome (IBS), the most common functional gastrointestinal disorder, is characterized by chronic abdominal pain and bowel habit changes. Although diverse complicated etiologies are involved in its pathogenesis, a dysregulated gut-brain axis may be an important factor. Red ginseng (RG), a traditional herbal medicine, is proven to have anti-inflammatory effects and improve brain function; however, these effects have not been investigated in IBS. Methods: Three-day intracolonic zymosan injections were used to induce post-infectious human IBS-like symptoms in mice. The animals were randomized to receive either phosphate-buffered saline (CG) or RG (30/100/300 mg/kg) for 10 days. Amitriptyline and sulfasalazine were used as positive controls. Macroscopic scoring was performed on day 4. Visceral pain and anxiety-like behaviors were assessed by colorectal distension and elevated plus maze and open field tests, respectively, on day 10. Next-generation sequencing of gut microbiota was performed, and biomarkers involved in gut-brain axis responses were analyzed. Results: Compared to CG, RG significantly decreased the macroscopic score, frequency of visceral pain, and anxiety-like behavior in the IBS mice. These effects were comparable to those after sulfasalazine and amitriptyline treatments. Moreover, RG significantly increased the proliferation of beneficial microbes, including Lactobacillus johnsonii, Lactobacillus reuteri, and Parabacteroides goldsteinii. RG significantly suppressed expression of IL-1β and c-fos in the gut and prefrontal cortex, respectively. Further, it restored the plasma levels of corticosterone to within the normal range, accompanied by an increase in adrenocorticotropic hormone. Conclusion: RG may be a potential therapeutic option for the management of human IBS.

• 재활복지공학회논문지
• /
• 제11권3호
• /
• pp.207-214
• /
• 2017

몸통안정성에 문제가 발생하면 허리에 통증이 발생된다. 허리 불안정성을 해소하기 위한 몸통안정화운동 방법 중 하나인 복부드로우인기법(ADIM)은 복부안정화근육 중 선행적자세조절과 관련된 배가로근에 대한 선택적인 수축을 유도하는 운동법이다. ADIM은 일반적으로 바로누운자세에서 허리 밑에 압력생체되먹임장치(PBU)을 적용하여 시각적되먹임을 한 상태에서 실시하는데 이러한 자세는 앉은자세에 비해 기능적이지 못하다. 본 연구에서는 바로누운자세와 앉은자세에서 실시하는 ADIM의 효과를 알아보기 위해 31명의 건강한 남녀를 대상으로 무선 근전도를 이용해 배곧은근(RA), 배바깥빗근(EO), 배가로근/배속빗근(TrA/IO), 그리고 척추세움근(ES)에 대한 근활성도를 비교하였다. 본 연구 결과 RA와 EO에서는 두 자세 간에 유의한 차이가 없었으며 TrA/IO와 ES에서는 두 자세 간에 유의한 차이가 나타났다. 또 RA에 비해 TrA/IO의 활성도가 높게 나타나 ADIM로 인한 몸통안정화는 두 자세 모두에서 효과적으로 나타났으며 반면 TrA/IO와 ES는 앉은 자세에서 더 높은 활성도를 보여 자세 안정화 근육의 활성도가 앉은 자세에서 더 증가한 것으로 사료된다. 따라서 일상생활에서 보다 쉽게 적용할 수 있는 앉은 자세의 ADIM은 허리안정성 향상에 유용할 것이다.

• 대한한방내과학회지
• /
• 제43권5호
• /
• pp.960-966
• /
• 2022

Objectives: Irritable bowel syndrome is a functional disorder of the gastrointestinal tract marked by chronic abdominal pain and altered bowel habits. Irritable bowel syndrome is experienced by 11% of the global population. Although antidepressants and antispasmodic agents are currently used as therapeutic methods, they have side effects, so safer treatment agents are needed. Hence, I report the case of an outpatient who suffers from irritable bowel syndrome. Methods: The patient visited a public health center 14 times over four weeks and was treated with acupuncture and herbal medicine (Sosiho-tang and Jakyakgamcho-tang). Treatment progress was assessed using the Irritable Bowel Syndrome Severity Scoring System. Results: After 28 days of treatment, the Irritable Bowel Syndrome Severity Scoring System score decreased from 410 to 30 points without adverse events. The patient was highly satisfied. Conclusion: Sosiho-tang and Jakyakgamcho-tang with acupuncture might become recommended therapeutic options for irritable bowel syndrome patients.

• Journal of Yeungnam Medical Science
• /
• 제40권4호
• /
• pp.435-441
• /
• 2023

Pheochromocytomas and paragangliomas (PPGLs) may secrete hormones or bioactive neuropeptides such as interleukin-6 (IL-6), which can mask the clinical manifestations of catecholamine hypersecretion. We report the case of a patient with delayed diagnosis of paraganglioma due to the development of IL-6-mediated systemic inflammatory response syndrome (SIRS). A 58-year-old woman presented with dyspnea and flank pain accompanied by SIRS and acute cardiac, kidney, and liver injuries. A left paravertebral mass was incidentally observed on abdominal computed tomography (CT). Biochemical tests revealed increased 24-hour urinary metanephrine (2.12 mg/day), plasma norepinephrine (1,588 pg/mL), plasma normetanephrine (2.27 nmol/L), and IL-6 (16.5 pg/mL) levels. ¹⁸F-fluorodeoxyglucose (FDG) positron emission tomography/CT showed increased uptake of FDG in the left paravertebral mass without metastases. The patient was finally diagnosed with functional paraganglioma crisis. The precipitating factor was unclear, but phendimetrazine tartrate, a norepinephrine-dopamine release drug that the patient regularly took, might have stimulated the paraganglioma. The patient's body temperature and blood pressure were well controlled after alpha-blocker administration, and the retroperitoneal mass was surgically resected successfully. After surgery, the patient's inflammatory, cardiac, renal, and hepatic biomarkers and catecholamine levels improved. In conclusion, our report emphasizes the importance of IL-6-producing PPGLs in the differential diagnosis of SIRS.

• Clinical and Experimental Pediatrics
• /
• 제51권4호
• /
• pp.391-395
• /
• 2008

목 적 : 만성기능성 변비소아의 분변박힘제거 단계에서 전해질이 함유지 않은 PEG 4000의 적절한 용량, 효과 및 안전성에 대한 연구를 시행하였다. 방 법 : 2004년 3월부터 2006년 8월까지 건국대학교병원 소아과에서 만성기능성 변비로 진단된 환아 86명을 대상으로 전향적으로 시행하였으며, 주증상의 완화, 배변횟수와 배변 용이함의 향상, 복부 X선 검사 상 대변양의 감소 가운데 2가지를 충족하면 분변박힘제거가 성공적인 것으로 판단하였다. 치료효과를 판정하기위해 보호자나 환아가 기록한 변비 일지를 바탕으로 PEG 4000 복용전과 복용후의 주증상, 평균 배변횟수, 변의 굳기 및 단순 복부 X-선 사진을 비교하였으며, 임상적 증상 관찰과 함께 일반혈액검사와 전해질 검사, 칼슘, 마그네슘, 혈청삼투압검사를 시행하여 부작용을 확인하였다. 결 과 : 연구를 마친 83명 가운데 82명에서 분변박힘제거에 성공하였으며(99%), 분변박힘제거에 필요한 전해질이 함유되지 않은 PEG 4000의 평균용량은 $0.93{\pm}0.28g/kg/day$ (0.4-2.0 g/kg/day, 최대용량 30 g/day)이었다. 배변횟수는 83명 가운데 79명의 환아에서 치료 후에 배변횟수가 증가되었으며(평균 배변횟수 $5.02{\pm}2.71$회/1주 vs. $11.25{\pm}5.43$회/1주), 배변도 수월하고, 주증상도 거의 모든 환자에서 호전되었다. 치료 전후의 단순 복부 X-선 사진을 비교하였을 때, 통계학적으로 의미 있게 호전된 소견을 보였다(P=0.0007). 임상적으로 두드러기 1명, 심한 설사 1명과 설사와 복통 1명, 총 3명이 치료를 마치지 못하였으며, 대상 군에서는 손발 저림 증상이 1명에서 나타났으나, 약제 중단 후 아무런 처치 없이 호전되었다(4/86=4.7%). 검사소견상 1명에서 고삼투압혈증이 관찰되었으나, 임상적으로 증상이 관찰되지 않았으며, 6명에서 호산구 증가가 관찰되었다. 결 론 : 만성 기능성변비환아의 분변박힘제거에 안전하고 효과적인 PEG 4000 용량은 $0.93{\pm}0.28g/kg/day$ (최대용량 30 g/ day)로 생각된다.

• 대한한방내과학회지
• /
• 제26권4호
• /
• pp.785-794
• /
• 2005

Little is known concerning the pathophysiology and symptomatology of gastric dysmotility of patients who have sought treatment in eastern traditional medicine. The aim of this study was to investigate gastric electrical activity and clinical characteristics between gastroparesis and non-gastroparetic functional dyspepsia(FD) and assess the necessity to distinguish them for eastern traditional medical treatment. 60 patients were surveyed by questionnaire. Gastric electrical activity was recorded and analyzed using electrogas-trography. Patients were divided into gastroparesis and non-gastroparetic FD by 1.0 of power ratio. Healthy persons were used as reference. Postprandial normogastria of gastroparesis decreased and that of non-gastroparetic functional dyspepsia increased compared before and after meals. Suggested causes of onset were the meat diets that most patients were on in the gastroparesis group, and that drugs that patients in the non-gastroparetic FD group were taking. Distribution of main symptom was equally regular in patients with gastroparesis, but patients with non-gastroparetic FD showed mainly upper abdominal pain and fullness. Values for the gastroparesis group were double those for the non-gastroparesis FD group in frequency of upper GI endosopic examination. Results suggest that effective application of eastern traditional medical treatment requires that first a clear distinction be made in state of gastric dysmotility and clinical characteristics of gastroparesis and non-gastroparesis FD when treating dyspepsia.

• 재활복지공학회논문지
• /
• 제7권2호
• /
• pp.85-90
• /
• 2013

복부 중심근육(core muscle)은 근골격계 및 신경계 환자의 재활에 있어 통증, 균형 및 상 하지의 기능적 움직임을 이끌어내는데 중요한 역할을 한다. 본 연구에서는 복부 운동근(global muscle)인 배곧은근과 고정근(local muscle)인 배가로근, 배속빗근 및 배바깥빗근의 두께 및 근력을 증가시킬 목적으로 저주파 전기자극기를 개발하였다. 연구대상자는 20대 여성 15명으로, 대조군과 실험군(기존제품 사용군 및 개발제품 사용군)으로 나뉘었다. 실험군에서는 저주파 전기자극을 4주 동안 주 4회, 30분씩 시행한 후 근전도 및 초음파 검사를 하였다. 연구 결과, 대조군, 기존제품 사용군, 개발제품 사용군의 세 군 중 개발제품 사용군에서 배곧은근의 근활성도가 의미있게 증가하였다(p<.05). 초음파로 측정된 근육 두께 변화율에서는 기존제품 사용군에서는 배가로근이, 개발제품 사용군에서는 배가로근과 배바깥빗근이 모두 유의하게 증가하였다(p<.05). 본 연구 결과를 통해 심각한 중추신경계 손상으로 인해 자발적인 근수축이 어렵거나 허리 수술 후 재활운동의 시작단계를 위해 근거 중심의 선택적 저주파 전기자극은 효과적인 중재방법의 하나로써 활용가치가 있다고 사료된다.